US2020138839A1PendingUtilityA1

Glucose infusion solution composition

42
Assignee: LEE GEON MOOPriority: Mar 15, 2017Filed: Mar 13, 2018Published: May 7, 2020
Est. expiryMar 15, 2037(~10.6 yrs left)· nominal 20-yr term from priority
Inventors:Geon Moo LeeIn Seong LeeJun Seong LeeMi Boon ChungJin Kyu Song
A61K 9/08A61K 47/18A61K 31/7004A61K 47/183A61K 31/7008A61K 9/0019
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An infusion solution composition having enhanced stability is disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An infusion solution composition comprising glucose, galactose, mannose, L-fucose, xylose, N-acetylglucosamine, N-acetylgalactosamine and N-acetylneuraminic acid. 
     
     
         2 . The infusion solution composition of  claim 1 , further comprising a stabilizer. 
     
     
         3 . The infusion solution composition of  claim 2 , wherein the stabilizer is an amino acid. 
     
     
         4 . The infusion solution composition of  claim 3 , wherein the amino acid is one or more selected from the group consisting of methionine, phenylalanine, histidine and aspartic acid. 
     
     
         5 . The infusion solution composition of  claim 2 , wherein the stabilizer is aspartic acid. 
     
     
         6 . The infusion solution composition of  claim 1 , wherein the infusion solution composition comprises methionine, phenylalanine, histidine and aspartic acid as stabilizers.

Join the waitlist — get patent alerts

Track US2020138839A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.